Activation of central GABA(A) but not of GABA(B) - receptors rapidly reduces pituitary LH release and GnRH gene expression in the preoptic/anterior hypothalamic area of ovariectomized rats

S. Leonhardt, Jae Young Seong, K. Kim, Y. Thorun, W. Wuttke, H. Jarry

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

γ-Aminobutyric acid (GABA) exerts an inhibitory action on gonadotropin-releasing hormone (GnRH) release from the hypothalamus. In vivo, this inhibitory action appears to be mediated via the GABA(A) receptor since in ovariectomized (ovx) rats and sheep direct application of muscimol (MUS), a GABA(A) agonist, into the preoptic area (POA), the site were the GnRH cell bodies are located, caused an immediate reduction of LH release. This effect Gonadotropins may be the result of an inhibition of GnRH release but also GnRH biosynthesis may be affected. Using competitive reverse transcription-polymerase chain reaction (RT-PCR) we now addressed the question, whether an acute inhibition of the GnRH pulse generator in ovx rats by GABA involves reduction of GnRH biosynthesis as determined by GnRH mRNA levels in micropunches of the POA. To activate either the GABA(A) or GABA(B) receptor, we injected intraventricularly (icv) MUS or baclofen (BAC). Intracerebroventricular injection of 10nmol MUS caused a rapid and lasting inhibition of LH release from about 7.5ng/ml (pretreatment value) to approximately 1.5ng/ml. Neither application of BAC or saline (control injections) affected LH secretion. Two hours after icv injections, rats were decapitated and GnRH mRNA levels were determined. MUS induced a pronounced decrease of GnRH levels in the POA (control rats: 2.26pg GnRH mRNA; MUS-treated rats: 0.85pg, n=10/group). BAC was without any effect on GnRH mRNA levels. Thus, we confirm the inhibitory action of GABA on LH release in vivo which is exerted via the A-subtype of the receptor. We suggest that this effect, in addition to the possible actions of MUS on other neuronal systems relevant to central regulation of LH secretion, is at least in part due to a similarly rapid suppression of GnRH gene expression in the POA and/or accelerated GnRH mRNA turnover.

Original languageEnglish
Pages (from-to)655-662
Number of pages8
JournalNeuroendocrinology
Volume61
Issue number6
Publication statusPublished - 1995 Jan 1
Externally publishedYes

Fingerprint

Anterior Hypothalamic Nucleus
GABA-B Receptors
Gonadotropin-Releasing Hormone
gamma-Aminobutyric Acid
Gene Expression
Muscimol
Preoptic Area
Baclofen
Messenger RNA
Injections
GABA-A Receptor Agonists
Aminobutyrates
GABA-A Receptors
Gonadotropins

Keywords

  • GABA
  • GABA receptors
  • Gonadal steroids
  • Gonadotropin-releasing hormone
  • Gonadotropin-releasing hormone gene expression
  • Gonadotropins
  • Preoptic area

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Activation of central GABA(A) but not of GABA(B) - receptors rapidly reduces pituitary LH release and GnRH gene expression in the preoptic/anterior hypothalamic area of ovariectomized rats. / Leonhardt, S.; Seong, Jae Young; Kim, K.; Thorun, Y.; Wuttke, W.; Jarry, H.

In: Neuroendocrinology, Vol. 61, No. 6, 01.01.1995, p. 655-662.

Research output: Contribution to journalArticle

@article{d2956ed62c7a4cd7956636829dc609c6,
title = "Activation of central GABA(A) but not of GABA(B) - receptors rapidly reduces pituitary LH release and GnRH gene expression in the preoptic/anterior hypothalamic area of ovariectomized rats",
abstract = "γ-Aminobutyric acid (GABA) exerts an inhibitory action on gonadotropin-releasing hormone (GnRH) release from the hypothalamus. In vivo, this inhibitory action appears to be mediated via the GABA(A) receptor since in ovariectomized (ovx) rats and sheep direct application of muscimol (MUS), a GABA(A) agonist, into the preoptic area (POA), the site were the GnRH cell bodies are located, caused an immediate reduction of LH release. This effect Gonadotropins may be the result of an inhibition of GnRH release but also GnRH biosynthesis may be affected. Using competitive reverse transcription-polymerase chain reaction (RT-PCR) we now addressed the question, whether an acute inhibition of the GnRH pulse generator in ovx rats by GABA involves reduction of GnRH biosynthesis as determined by GnRH mRNA levels in micropunches of the POA. To activate either the GABA(A) or GABA(B) receptor, we injected intraventricularly (icv) MUS or baclofen (BAC). Intracerebroventricular injection of 10nmol MUS caused a rapid and lasting inhibition of LH release from about 7.5ng/ml (pretreatment value) to approximately 1.5ng/ml. Neither application of BAC or saline (control injections) affected LH secretion. Two hours after icv injections, rats were decapitated and GnRH mRNA levels were determined. MUS induced a pronounced decrease of GnRH levels in the POA (control rats: 2.26pg GnRH mRNA; MUS-treated rats: 0.85pg, n=10/group). BAC was without any effect on GnRH mRNA levels. Thus, we confirm the inhibitory action of GABA on LH release in vivo which is exerted via the A-subtype of the receptor. We suggest that this effect, in addition to the possible actions of MUS on other neuronal systems relevant to central regulation of LH secretion, is at least in part due to a similarly rapid suppression of GnRH gene expression in the POA and/or accelerated GnRH mRNA turnover.",
keywords = "GABA, GABA receptors, Gonadal steroids, Gonadotropin-releasing hormone, Gonadotropin-releasing hormone gene expression, Gonadotropins, Preoptic area",
author = "S. Leonhardt and Seong, {Jae Young} and K. Kim and Y. Thorun and W. Wuttke and H. Jarry",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "61",
pages = "655--662",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Activation of central GABA(A) but not of GABA(B) - receptors rapidly reduces pituitary LH release and GnRH gene expression in the preoptic/anterior hypothalamic area of ovariectomized rats

AU - Leonhardt, S.

AU - Seong, Jae Young

AU - Kim, K.

AU - Thorun, Y.

AU - Wuttke, W.

AU - Jarry, H.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - γ-Aminobutyric acid (GABA) exerts an inhibitory action on gonadotropin-releasing hormone (GnRH) release from the hypothalamus. In vivo, this inhibitory action appears to be mediated via the GABA(A) receptor since in ovariectomized (ovx) rats and sheep direct application of muscimol (MUS), a GABA(A) agonist, into the preoptic area (POA), the site were the GnRH cell bodies are located, caused an immediate reduction of LH release. This effect Gonadotropins may be the result of an inhibition of GnRH release but also GnRH biosynthesis may be affected. Using competitive reverse transcription-polymerase chain reaction (RT-PCR) we now addressed the question, whether an acute inhibition of the GnRH pulse generator in ovx rats by GABA involves reduction of GnRH biosynthesis as determined by GnRH mRNA levels in micropunches of the POA. To activate either the GABA(A) or GABA(B) receptor, we injected intraventricularly (icv) MUS or baclofen (BAC). Intracerebroventricular injection of 10nmol MUS caused a rapid and lasting inhibition of LH release from about 7.5ng/ml (pretreatment value) to approximately 1.5ng/ml. Neither application of BAC or saline (control injections) affected LH secretion. Two hours after icv injections, rats were decapitated and GnRH mRNA levels were determined. MUS induced a pronounced decrease of GnRH levels in the POA (control rats: 2.26pg GnRH mRNA; MUS-treated rats: 0.85pg, n=10/group). BAC was without any effect on GnRH mRNA levels. Thus, we confirm the inhibitory action of GABA on LH release in vivo which is exerted via the A-subtype of the receptor. We suggest that this effect, in addition to the possible actions of MUS on other neuronal systems relevant to central regulation of LH secretion, is at least in part due to a similarly rapid suppression of GnRH gene expression in the POA and/or accelerated GnRH mRNA turnover.

AB - γ-Aminobutyric acid (GABA) exerts an inhibitory action on gonadotropin-releasing hormone (GnRH) release from the hypothalamus. In vivo, this inhibitory action appears to be mediated via the GABA(A) receptor since in ovariectomized (ovx) rats and sheep direct application of muscimol (MUS), a GABA(A) agonist, into the preoptic area (POA), the site were the GnRH cell bodies are located, caused an immediate reduction of LH release. This effect Gonadotropins may be the result of an inhibition of GnRH release but also GnRH biosynthesis may be affected. Using competitive reverse transcription-polymerase chain reaction (RT-PCR) we now addressed the question, whether an acute inhibition of the GnRH pulse generator in ovx rats by GABA involves reduction of GnRH biosynthesis as determined by GnRH mRNA levels in micropunches of the POA. To activate either the GABA(A) or GABA(B) receptor, we injected intraventricularly (icv) MUS or baclofen (BAC). Intracerebroventricular injection of 10nmol MUS caused a rapid and lasting inhibition of LH release from about 7.5ng/ml (pretreatment value) to approximately 1.5ng/ml. Neither application of BAC or saline (control injections) affected LH secretion. Two hours after icv injections, rats were decapitated and GnRH mRNA levels were determined. MUS induced a pronounced decrease of GnRH levels in the POA (control rats: 2.26pg GnRH mRNA; MUS-treated rats: 0.85pg, n=10/group). BAC was without any effect on GnRH mRNA levels. Thus, we confirm the inhibitory action of GABA on LH release in vivo which is exerted via the A-subtype of the receptor. We suggest that this effect, in addition to the possible actions of MUS on other neuronal systems relevant to central regulation of LH secretion, is at least in part due to a similarly rapid suppression of GnRH gene expression in the POA and/or accelerated GnRH mRNA turnover.

KW - GABA

KW - GABA receptors

KW - Gonadal steroids

KW - Gonadotropin-releasing hormone

KW - Gonadotropin-releasing hormone gene expression

KW - Gonadotropins

KW - Preoptic area

UR - http://www.scopus.com/inward/record.url?scp=0028990167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028990167&partnerID=8YFLogxK

M3 - Article

C2 - 7544879

AN - SCOPUS:0028990167

VL - 61

SP - 655

EP - 662

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 6

ER -